vs
BIOLIFE SOLUTIONS INC（BLFS）与CareCloud, Inc.（CCLD）财务数据对比。点击上方公司名可切换其他公司
CareCloud, Inc.的季度营收约是BIOLIFE SOLUTIONS INC的1.8倍（$34.4M vs $18.8M），BIOLIFE SOLUTIONS INC同比增速更快（24.3% vs 21.9%），过去两年CareCloud, Inc.的营收复合增速更高（15.1% vs 1.0%）
BIOLIFE SOLUTIONS INC专注于开发生物保存产品及冷链管理解决方案，服务于细胞与基因治疗、生物制药及再生医学领域，产品涵盖低温保存培养基、自动化解冻系统、温度监测工具，为全球相关企业、科研机构及临床实验室提供支持。
CareCloud, Inc.是一家上市的美国医疗信息技术企业，主要为各类医疗机构、医院提供专业医疗信息化相关服务，公司总部位于新泽西州萨默塞特，目前在全球拥有约四千名员工。
BLFS vs CCLD — 直观对比
营收规模更大
CCLD
是对方的1.8倍
$18.8M
营收增速更快
BLFS
高出2.4%
21.9%
两年增速更快
CCLD
近两年复合增速
1.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $18.8M | $34.4M |
| 净利润 | $11.1M | — |
| 毛利率 | — | — |
| 营业利润率 | 7.2% | 9.1% |
| 净利率 | 58.9% | — |
| 营收同比 | 24.3% | 21.9% |
| 净利润同比 | -11.1% | — |
| 每股收益（稀释后） | $0.23 | $0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BLFSCCLD
| Q4 25 | $18.8M | $34.4M | ||
| Q3 25 | $28.1M | $31.1M | ||
| Q2 25 | $25.4M | $27.4M | ||
| Q1 25 | $23.9M | $27.6M | ||
| Q4 24 | $15.1M | $28.2M | ||
| Q3 24 | $21.4M | $28.5M | ||
| Q2 24 | $19.7M | $28.1M | ||
| Q1 24 | $18.4M | $26.0M |
净利润BLFSCCLD
| Q4 25 | $11.1M | — | ||
| Q3 25 | $621.0K | $3.1M | ||
| Q2 25 | $-15.8M | $2.9M | ||
| Q1 25 | $-448.0K | $1.9M | ||
| Q4 24 | $12.5M | — | ||
| Q3 24 | $-1.7M | $3.1M | ||
| Q2 24 | $-20.7M | $1.7M | ||
| Q1 24 | $-10.2M | $-241.0K |
营业利润率BLFSCCLD
| Q4 25 | 7.2% | 9.1% | ||
| Q3 25 | -0.3% | 10.3% | ||
| Q2 25 | -65.5% | 10.9% | ||
| Q1 25 | -5.1% | 7.3% | ||
| Q4 24 | 3.6% | 12.2% | ||
| Q3 24 | -2.0% | 11.4% | ||
| Q2 24 | -6.6% | 8.1% | ||
| Q1 24 | -17.9% | 0.5% |
净利率BLFSCCLD
| Q4 25 | 58.9% | — | ||
| Q3 25 | 2.2% | 9.8% | ||
| Q2 25 | -62.3% | 10.6% | ||
| Q1 25 | -1.9% | 7.0% | ||
| Q4 24 | 82.5% | — | ||
| Q3 24 | -8.0% | 10.9% | ||
| Q2 24 | -105.1% | 6.0% | ||
| Q1 24 | -55.4% | -0.9% |
每股收益（稀释后）BLFSCCLD
| Q4 25 | $0.23 | $0.06 | ||
| Q3 25 | $0.01 | $0.04 | ||
| Q2 25 | $-0.33 | $0.04 | ||
| Q1 25 | $-0.01 | $-0.04 | ||
| Q4 24 | $0.27 | $0.00 | ||
| Q3 24 | $-0.04 | $-0.04 | ||
| Q2 24 | $-0.45 | $-0.14 | ||
| Q1 24 | $-0.22 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.0M | — |
| 总债务越低越好 | $5.0M | $1.2M |
| 股东权益账面价值 | $371.9M | $59.5M |
| 总资产 | $405.9M | $87.6M |
| 负债/权益比越低杠杆越低 | 0.01× | 0.02× |
8季度趋势，按日历期对齐
现金及短期投资BLFSCCLD
| Q4 25 | $33.0M | — | ||
| Q3 25 | $29.5M | — | ||
| Q2 25 | $31.9M | — | ||
| Q1 25 | $66.9M | — | ||
| Q4 24 | $91.5M | — | ||
| Q3 24 | $24.0M | — | ||
| Q2 24 | $22.0M | — | ||
| Q1 24 | $29.7M | — |
总债务BLFSCCLD
| Q4 25 | $5.0M | $1.2M | ||
| Q3 25 | $7.5M | — | ||
| Q2 25 | $10.1M | — | ||
| Q1 25 | $12.9M | — | ||
| Q4 24 | $15.9M | $336.0K | ||
| Q3 24 | $20.1M | — | ||
| Q2 24 | $21.1M | — | ||
| Q1 24 | $24.3M | — |
股东权益BLFSCCLD
| Q4 25 | $371.9M | $59.5M | ||
| Q3 25 | $353.7M | $57.8M | ||
| Q2 25 | $347.2M | $56.1M | ||
| Q1 25 | $352.6M | $54.2M | ||
| Q4 24 | $348.9M | $49.8M | ||
| Q3 24 | $325.5M | $46.5M | ||
| Q2 24 | $321.4M | $43.2M | ||
| Q1 24 | $333.4M | $41.4M |
总资产BLFSCCLD
| Q4 25 | $405.9M | $87.6M | ||
| Q3 25 | $392.1M | $90.6M | ||
| Q2 25 | $387.2M | $75.2M | ||
| Q1 25 | $395.1M | $73.6M | ||
| Q4 24 | $399.5M | $71.6M | ||
| Q3 24 | $381.7M | $70.7M | ||
| Q2 24 | $375.0M | $74.0M | ||
| Q1 24 | $401.6M | $76.9M |
负债/权益比BLFSCCLD
| Q4 25 | 0.01× | 0.02× | ||
| Q3 25 | 0.02× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.04× | — | ||
| Q4 24 | 0.05× | 0.01× | ||
| Q3 24 | 0.06× | — | ||
| Q2 24 | 0.07× | — | ||
| Q1 24 | 0.07× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $4.9M | $8.7M |
| 自由现金流经营现金流 - 资本支出 | — | $6.6M |
| 自由现金流率自由现金流/营收 | — | 19.0% |
| 资本支出强度资本支出/营收 | — | 6.2% |
| 现金转化率经营现金流/净利润 | 0.44× | — |
| 过去12个月自由现金流最近4个季度 | — | $23.8M |
8季度趋势，按日历期对齐
经营现金流BLFSCCLD
| Q4 25 | $4.9M | $8.7M | ||
| Q3 25 | $6.1M | $7.4M | ||
| Q2 25 | $7.4M | $7.4M | ||
| Q1 25 | $1.7M | $5.1M | ||
| Q4 24 | $1.6M | $5.2M | ||
| Q3 24 | $4.8M | $7.1M | ||
| Q2 24 | $6.5M | $4.3M | ||
| Q1 24 | $-4.5M | $4.1M |
自由现金流BLFSCCLD
| Q4 25 | — | $6.6M | ||
| Q3 25 | — | $6.5M | ||
| Q2 25 | — | $6.2M | ||
| Q1 25 | — | $4.5M | ||
| Q4 24 | — | $4.3M | ||
| Q3 24 | — | $6.7M | ||
| Q2 24 | — | $4.2M | ||
| Q1 24 | — | $3.8M |
自由现金流率BLFSCCLD
| Q4 25 | — | 19.0% | ||
| Q3 25 | — | 20.9% | ||
| Q2 25 | — | 22.8% | ||
| Q1 25 | — | 16.2% | ||
| Q4 24 | — | 15.2% | ||
| Q3 24 | — | 23.6% | ||
| Q2 24 | — | 14.8% | ||
| Q1 24 | — | 14.5% |
资本支出强度BLFSCCLD
| Q4 25 | — | 6.2% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 4.2% | ||
| Q1 25 | — | 2.3% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | 1.1% |
现金转化率BLFSCCLD
| Q4 25 | 0.44× | — | ||
| Q3 25 | 9.83× | 2.41× | ||
| Q2 25 | — | 2.55× | ||
| Q1 25 | — | 2.62× | ||
| Q4 24 | 0.13× | — | ||
| Q3 24 | — | 2.26× | ||
| Q2 24 | — | 2.56× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BLFS
暂无分部数据
CCLD
| Healthcare IT | $31.0M | 90% |
| Medical Practice Management | $3.4M | 10% |
